
Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -30.138 | -42.666 | -44.641 | -29.585 | -24.192 | -31.466 | -11.937 | -6.894 |
Return on Equity (%) | -36.542 | -49.635 | -64.664 | -69.923 | -106.307 | -526.144 | 232.399 | 362.287 |
Return on Invested Capital (%) | -42.702 | -53.884 | -70.058 | -65.765 | -61.157 | -82.171 | -40.288 | -16.028 |
Operating Margin (%) | -545.949 | -1015.478 | -402.846 | -156.457 | -83.991 | -93.6 | -17.081 | -10.476 |
Net Profit Margin (%) | -545.949 | -1016.576 | -403.238 | -174.145 | -101.011 | -109.036 | -24.079 | -12.372 |
Book Value Per Share | 17.723 | 12.868 | 12.824 | 8.729 | 4.894 | -1.277 | -1.758 | 0.52 |
Earnings Per Share | -4.925 | -7.526 | -7.898 | -7.372 | -7.096 | -9.128 | -3.508 | -2.157 |
Cash Per Share | 6.475 | 4.153 | 4.877 | 4.265 | 6.823 | 6.991 | 6.476 | 7.493 |
Working Capital Per Share | 16.259 | 10.093 | 12.152 | 17.432 | 17.581 | 15.528 | 16.056 | 16.351 |
Operating Profit Per Share | 0.902 | 0.723 | 1.735 | 3.563 | 6.255 | 7.368 | 12.526 | 15.363 |
EBIT Per Share | -4.925 | -7.518 | -7.891 | -7.349 | -7.09 | -9.094 | -3.455 | -2.926 |
EBITDA Per Share | -4.925 | -7.518 | -7.891 | -7.349 | -7.09 | -9.094 | -3.455 | -2.926 |
Free Cash Flow Per Share | -3.999 | -6.399 | -6.797 | -7.027 | -6.856 | -8.905 | -3.443 | -2.33 |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 99.67M | 101.18M | 112.19M | 116.43M | 120.18M | 123.93M | N/A | N/A |
Year End December 30 2024 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -44.914 | N/A | N/A | N/A | -5.732 | N/A | N/A | N/A |
Net Profit Margin (%) | -54.528 | N/A | N/A | N/A | -13.338 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 31.53B |
Price to Earnings Ratio | -113.04 |
Price to Sales Ratio | 13.98 |
Price to Cash Ratio | 32.53 |
Price to Book Ratio | 468.66 |
Dividend Yield | - |
Shares Outstanding | 129.46M |
Average Volume (1 week) | 1.02M |
Average Volume (1 Month) | 779.75k |
52 Week Change | 58.61% |
52 Week High | 304.39 |
52 Week Low | 141.975 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.